Regeneron Pharmaceuticals, Inc.

REGNNASDAQHealthcare● Active

$635.45

+$6.72(+1.07%)

Market Cap$65.5B

P/E Ratio—

52W High$821.11

52W Low$476.49

Avg Volume831K

Open$632.26

Beta0.24

Overview

Regeneron Pharmaceuticals, Inc. (REGN) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

REGN · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$8.61B▼ -4.5% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$3.12B

cashAndCashEquivalents

Short-Term Investments

$5.49B

shortTermInvestments

YoY Change vs Prior Year

-4.5%

vs prior fiscal year

Latest Quarter

$8.75B

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$8.61BCash on Hand

Total Debt$2.71BTotal Debt

Net Cash / Net Debt+$5.90BNet Cash Position

Cash vs Debt Ratio

Cash 76%Regeneron Pharmaceuticals, Inc. cash as % of market cap: 13.14%% · MCap $65BDebt 24%

Regeneron Pharmaceuticals, Inc. has a net cash position of $5.90B, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$8.61B − $2.71B = +$5.90B

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

REGN annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

REGN cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$8.61B-4.5%

Dec 31, 2024FY$9.01B-16.9%

Dec 31, 2023FY$10.84B+40.1%

Dec 31, 2022FY$7.74B+36.0%

Dec 31, 2021FY$5.69B+58.8%

REGN cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

REGN vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Regeneron Pharmaceuticals, Inc.YOU

REGN

$8.61B$65B13.1%

31%

Eli Lilly and Company

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Regeneron Pharmaceuticals, Inc. (REGN) cash on hand as of December 31, 2025 is $8.61B, comprising $3.12B in cash and cash equivalents (CCE) plus $5.49B in short-term investments — reported as Regeneron Pharmaceuticals, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Regeneron Pharmaceuticals, Inc. cash reserves or cash position.

Regeneron Pharmaceuticals, Inc. annual cash on hand history shows decreased -4.5% in 2025: decreased -4.5% in 2025. Regeneron Pharmaceuticals, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Regeneron Pharmaceuticals, Inc. carries total debt of $2.71B against cash of $8.61B, resulting in a net cash position of +$5.90B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

REGN cash on hand · 5 questions

As of December 31, 2025, Regeneron Pharmaceuticals, Inc. (REGN) has $8.61B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $3.12B in cash and cash equivalents (CCE) plus $5.49B in short-term investments. Latest quarter (March 31, 2026): $8.75B. Data sourced from the annual 10-K filing via FMP.

REGN cash on handREGN cash reservesREGN cash 2025how much cash does REGN have

▸ Source: FMP /balance-sheet-statement · US GAAP · Regeneron Pharmaceuticals, Inc. · Regeneron Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025